ReviewThe journal of nutrition, health & aging2009
Validated treatments and therapeutic perspectives regarding nutritherapy.
Review in The journal of nutrition, health & aging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 26 citations in OpenAlex.
- A Case Report of Probable Secondary Sarcopenia After Intensive Care Hospitalization.Journal of frailty, sarcopenia and falls · 2024Article
- Muscle mass assessment in renal disease: the role of imaging techniques.Quantitative imaging in medicine and surgery · 2020Review
- Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation.Frontiers in nutrition · 2019Review
- Does vitamin-D intake during resistance training improve the skeletal muscle hypertrophic and strength response in young and elderly men? - a randomized controlled trial.Nutrition & metabolism · 2015Article
- Evaluation of sarcopenia in renal transplant recipients.Nephro-urology monthly · 2014Article
- Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes.The journal of nutrition, health & aging · 2013Review
- Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).The journal of nutrition, health & aging · 2011Article
- Frailty: diagnosis and management.The journal of nutrition, health & aging · 2011Article
- Assessment of malnutrition in older persons: a focus on the Mini Nutritional Assessment.The journal of nutrition, health & aging · 2011Article
- Nutritional determinants of mobility.Current opinion in clinical nutrition and metabolic care · 2010Review
- Carla Task Force on Sarcopenia: propositions for clinical trials.The journal of nutrition, health & aging · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutritherapy seeks to prevent or correct disease by the use of nutritional supplements including vitamins, trace elements, or macronutrients. This chapter of the "Les Entretiens du Carla" reviews the potential of nutritherapy for the prevention or improvement of sarcopenia, which is the progressive reduction in muscle mass and muscle strength prevalent in late-life. It is critical that we review nutrients and their potential to maintain muscle mass and strength which ultimately will help minimize falls and fractures among the older population. Evidence from randomized-controlled trials will be reviewed for muscle mass as well as important sarcopenia-related endpoints including lower extremity strength and function, as well as falls and fall-related fractures. This chapter will focus on vitamin D as a compelling strategy with evidence for strength gain, fall and fracture prevention from double-blind randomized controlled trials. The other strategy discussed is increased protein intake although longer-term trials and evidence for clinically important endpoints are limited. Today, there is no consistent data on other micronutrients or macronutrients with an established potential to combat sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.